Insider Trading February 27, 2026

Itron SVP Sells 519 Shares as Company Posts Strong Q4; Financing Move Also Noted

Donald L. Reeves III executed a Rule 10b5-1 sale of roughly $50.8k in ITRI stock while the company reported quarterly beats and completed a larger convertible note offering

By Hana Yamamoto ITRI
Itron SVP Sells 519 Shares as Company Posts Strong Q4; Financing Move Also Noted
ITRI

Donald L. Reeves III, senior vice president for Outcomes at Itron, Inc. (NASDAQ: ITRI), sold 519 shares on February 25, 2026, under a pre-existing Rule 10b5-1 trading plan. The sale, reported on a Form 4 with the SEC, generated approximately $50,778 in proceeds and left Reeves with 29,951 shares directly held. The transaction occurred as Itron shares trade near a 52-week low, even as the company reported fourth-quarter 2025 results that exceeded forecasts and completed a larger-than-announced private convertible note offering.

Key Points

  • Donald L. Reeves III sold 519 shares of Itron on February 25, 2026, at $97.84 per share, totaling about $50,778; he now directly holds 29,951 shares.
  • Itron beat fourth-quarter 2025 estimates with EPS of $2.46 versus $2.19 expected and revenue of $572 million versus $561.48 million forecast, prompting upgrades from Oppenheimer and Baird.
  • The company priced a $700 million convertible senior note offering due 2032, increased from $600 million, with an option for initial purchasers to buy an additional $105 million within a 13-day period.

Transaction details

Donald L. Reeves III, who serves as senior vice president, Outcomes at Itron, Inc. (NASDAQ: ITRI), sold 519 shares of the company's common stock on February 25, 2026. The shares were disposed at $97.84 apiece, producing gross proceeds of approximately $50,778, according to a Form 4 filing with the Securities and Exchange Commission. After the sale, Reeves is reported to directly own 29,951 shares of Itron common stock.


Trading plan and context

The reported transactions were carried out pursuant to a Rule 10b5-1 trading plan that Reeves adopted on September 11, 2025. The sale was recorded in the required SEC filing that details the transaction and resulting direct holdings.


Market and valuation snapshot

The insider sale took place while Itron shares were trading near their 52-week low of $88.57, with the quoted price at $94.36 at the time of reporting. InvestingPro analysis included in the filing indicates that the stock is classified as undervalued based on its Fair Value assessment, and lists Itron among companies on the Most Undervalued list. The company is reported to carry a price-to-earnings ratio of 14.59 and a market capitalization of $4.25 billion. A Pro Research Report on ITRI is available through the platform for readers seeking additional detail.


Earnings and analyst reaction

Itron announced fourth-quarter 2025 results that topped analysts' expectations. The company posted earnings per share of $2.46, versus a consensus forecast of $2.19, and reported revenue of $572 million, ahead of the anticipated $561.48 million. In the wake of the results and the fiscal 2026 guidance that accompanied them, Oppenheimer raised its price target on Itron shares to $133 from $125 while maintaining an Outperform rating. Baird likewise upgraded Itron to Outperform from Neutral and lifted its price target to $128 from $118, citing the company's multi-year opportunity in utility grid modernization.


Financing activity

Separately, Itron recently priced a private offering of $700 million in convertible senior notes due 2032, up from an earlier announcement of $600 million in size. The company granted initial purchasers an option to acquire an additional $105 million in notes during a 13-day period beginning on the first day of issuance. Those transactions were described as reflective of the company's strategic financial positioning.


Takeaway

The insider sale by Reeves is a disclosed, plan-driven transaction recorded on Form 4, occurring amid a period in which the stock trades near its 52-week low even as recent quarterly results and broker upgrades have been positive. The company has also executed a larger convertible note placement, which, together with the earnings beat and analyst revisions, forms the current backdrop for Itron's shares and investor assessment.

Risks

  • Insider sale executed while shares trade near the 52-week low of $88.57 - an indicator of market uncertainty impacting the stock and investor sentiment in the equities market.
  • The $700 million convertible senior note offering alters the company’s financing picture and could affect capital structure considerations in the corporate and fixed-income markets.
  • Market valuation remains under scrutiny despite analyst upgrades; metrics cited include a P/E of 14.59 and a market cap of $4.25 billion which market participants may reassess as new data emerges.

More from Insider Trading

Knight-Swift Finance Executive Sells $351K in Stock Amid Rally and Mixed Analyst Views Feb 27, 2026 Gold.com Director Disposes $2.8M in Shares Across Two Days Feb 27, 2026 Waste Management Accounting Chief Disposes Small Holdings Amid Q4 Miss Feb 27, 2026 Wabtec President Disposes $302K Stake as Shares Hover Near Yearly Peak Feb 27, 2026 Provident Financial Director Sells $136,697 in Stock; Company Posts Q4 2025 Beat Feb 27, 2026